Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/114603

In Collections

This item can be found in the following collections:

Mease, P.J.; Heijde, D. van der; Ritchlin, C.T.; Cuchacovich, R.S.; Shuler, C.L.; Lin, C.; ... ; Gladman, D.D. (2017)

A randomized, double-blind, active-and placebo-controlled phase 3 study of efficacy and safety of ixekizumab, adalimumab, and placebo therapy in patients naive to biologic disease-modifying antirheumatic drugs with active psoriatic arthritis

Article / Letter to editor
All authors
Mease, P.J.; Heijde, D. van der; Ritchlin, C.T.; Cuchacovich, R.S.; Shuler, C.L.; Lin, C.; Vangerow, H.; Samanta, S.; Lee, C.H.; Gladman, D.D.
Date
2017-03-31
Journal
Experimental Dermatology
Volume
26
Issue
3
Pages
E30 - E30